These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38324530)

  • 1. How do creative assets affect overseas market entry modes of enterprises- the moderating role of internal and external factors.
    Wang C; Tao K; Cui X; Qin S
    PLoS One; 2024; 19(2):e0296791. PubMed ID: 38324530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Social trust and the location choices of foreign firms in China-The moderating role of formal institution and cultural distance.
    Shen H; Yi C; Yu J; Gou J
    Front Psychol; 2023; 14():1061813. PubMed ID: 36910763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Why did they get in trouble? The influence of firm characteristics and institutional distance on Chinese firms' foreign market entry attempt.
    Zhang S
    Front Psychol; 2022; 13():972384. PubMed ID: 36148100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can Enterprises in China Achieve Sustainable Development through Green Investment?
    Zheng S; Jin S
    Int J Environ Res Public Health; 2023 Jan; 20(3):. PubMed ID: 36767154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of cultural friction on foreign divestment of multinational enterprises--the moderating role of formal institutional distance and political connections.
    Xu Z; Tian M; Zhang Y
    PLoS One; 2024; 19(2):e0295443. PubMed ID: 38335239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Geopolitical risk and green outward foreign direct investment location choice: evidence from Chinese listed companies.
    Du X; Tang C; Qi Q; Zhao Z
    Environ Sci Pollut Res Int; 2023 Oct; 30(47):103602-103619. PubMed ID: 37688694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of analyst attention on the firms' innovation paths from a life cycle perspective: Evidence from China.
    Yao J; Wang D
    Heliyon; 2023 Aug; 9(8):e18940. PubMed ID: 37636392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-border acquisition or greenfield investment? The role of investor sentiment.
    Dong L; Chen J
    Front Psychol; 2022; 13():1085286. PubMed ID: 36698567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk Assessment of Haier Group's Overseas Investment Under International Financial Reporting Standards.
    Zhong B; Soh WN; Ong TS; Muhammad HB; He CX
    Front Psychol; 2022; 13():889670. PubMed ID: 35668983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do institutional contingencies matter for green investment?-An institution based view of Chinese listed companies.
    Khan FU; Zhang J; Saeed I; Ullah S
    Heliyon; 2024 Jan; 10(1):e23456. PubMed ID: 38173482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effects of Open Innovation Based on Mergers and Acquisitions on Innovative Behavior of Enterprises: Evidence From Chinese Listed Enterprises.
    Wu M; Luo T; Tian Y
    Front Psychol; 2021; 12():794531. PubMed ID: 35126244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How diversification of overseas subsidiaries affects parent company innovation performance: evidence from China's multinationals.
    Wang S; Chen X; Ye J; Zhong C
    Front Psychol; 2024; 15():1344816. PubMed ID: 38770246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Impact of the Consistency Evaluation Policy of Generic Drugs on R&D Investment Intensity of Pharmaceutical Companies-An Empirical Study Based on the Difference-in-Differences Model.
    Wei Y; Zhu J; Qiao J; Zhang D; Chen Y
    Front Public Health; 2022; 10():902025. PubMed ID: 35757628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can technology-driven cross-border mergers and acquisitions promote green innovation in emerging market firms? Evidence from China.
    Li J
    Environ Sci Pollut Res Int; 2022 Apr; 29(19):27954-27976. PubMed ID: 34984618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stock Market Liberalization and Corporate Green Innovation: Evidence from China.
    Zhang Y; Zhang J; Cheng Z
    Int J Environ Res Public Health; 2021 Mar; 18(7):. PubMed ID: 33806099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tax preference, financing constraints and enterprise investment efficiency-Experience, of China's enterprises investment.
    Zhai L; Feng Y; Li F; Zhai L
    PLoS One; 2022; 17(9):e0274336. PubMed ID: 36137158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is state-owned enterprise merging private enterprise "market choice" or "space crowding" ? -Based on the motives of equity transfer of mixed-ownership enterprises.
    Mei-Sheng D; Hong GX; Yassir Hussain R; Tajeddini K
    Heliyon; 2023 Aug; 9(8):e19014. PubMed ID: 37654454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Foreign shareholder, overseas sale and corporate profit margin.
    Wen C
    PLoS One; 2024; 19(2):e0296021. PubMed ID: 38315684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effect of Environmental Policy Uncertainty on Enterprises' Pollution Emissions: Evidence from Chinese Industrial Enterprise.
    Le D; Ren F; Tang Y; Zhu Y
    Int J Environ Res Public Health; 2022 Aug; 19(16):. PubMed ID: 36011481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Internationalization tactics and enterprise value in the context of the "Belt and Road" initiative-Analysis from the perspective of host country institutional environment and enterprise digital transformation.
    Zhang D; Zheng X; Wang F
    PLoS One; 2023; 18(8):e0287324. PubMed ID: 37594995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.